Shire plc (ADR) (NASDAQ:SHPG)

ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Alibaba, ADM, CSC, Infosys, Microsoft, Wells Fargo, WisdomTree and More

Stocks were indicated higher on Thursday, after gains on Tuesday and Wednesday were handy. Oil also crossed back above the $50 barrier again for the first time since October 2015. ...
Read Full Story »
white pills

Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys

With earnings season hitting its stride this week, many investors are looking to see how the companies they own perform. Two areas that have lagged all year long are biotech ...
Read Full Story »
Pills and tablets

What to Expect From Baxalta Q4 Earnings

Baxalta Inc. (NYSE: BXLT) is scheduled to report fourth-quarter and full-year results before markets open on Tuesday. The hematology and immunology focused biopharmaceutical company is expected to post earnings per ...
Read Full Story »
automatic inspection machine

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

The end of 2015 and the start of 2016 have been hard on biotech, and in some cases have been hard for Big Pharma. It turns out that there is ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Akamai, BBVA, Dean Foods, SolarCity, Valero and Many More

Stocks got a big boost on news that Janet Yellen is talking down the Federal Reserve's desire to hike interest rates no matter what. Investors in 2016 have used rallies ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Stocks bounced on Thursday, but Friday's early trading indications were looking for a sharp sell-off of almost 2%, based on more oil and China weakness. This is also ahead of ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CA, CarMax, Dean Foods, Freeport-McMoRan, Newmont, Shire, Wells Fargo and Many More

Stocks tried to stabilize on Monday, and Tuesday's early indications were for Dow and S&P 500 futures to be up almost 1%. Last week's sell-off may have been the worst ...
Read Full Story »
Medical interface

Top Cowen Health Care and Biotech Best Idea Stock Picks for 2016

It’s that time of year again, the time when all the top firms that we cover here at 24/7 Wall St. start to make their stock picks and prognostications for ...
Read Full Story »
Pills and tablets

Dyax Agrees to $5.9 Billion Buyout

U.K.-based drugmaker Shire PLC (NASDAQ: SHPG) and Dyax Corp. (NASDAQ: DYAX) announced Monday morning that former will acquire latter for $37.30 in cash per share of Dyax for a total ...
Read Full Story »
ThinkstockPhotos-485280926

The Strongest Performing Biotech in 2015 Is a Surprise

Biotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the Biotechnology Index is up only 0.3%, pretty much breakeven. While ...
Read Full Story »
investing

SunTrust Has Q4 Portfolio ‘Catch-Up’ Stocks to Buy Now

Portfolio managers and others in charge of investments are facing the first down year in the markets since 2008. What can be even worse for active managers is trailing your ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: CyberArk, Goldman Sachs, Lululemon, Micron, Nike, Nokia, SanDisk and Many More

Stocks bounced handily on Monday after tanking on Friday. There is still a serious ongoing debate as to why Janet Yellen and the Federal Open Market Committee (FOMC) decided to ...
Read Full Story »
Boeing 757

3 Top-Rated Cowen Focus Call Stocks to Buy Now

With the Federal Reserve chatter quiet for at least the time being, after this week's announcement of no increase in interest rates, investors need to refocus on the top stock ...
Read Full Story »
payoff

2 Analysts Continue to Like Shire-Baxalta Deal Pursuit

Baxalta Inc. (NYSE: BXLT) has not been public as a standalone entity very long at all, when you consider that Shire PLC (NASDAQ: SHPG) is now interested in it. After ...
Read Full Story »
generic drugs

3 Specialty Pharma Stocks That Could Be Acquired in 2015

If there ever was a perfect storm for large pharmaceutical and big-cap biotech companies to make acquisitions to enhance growth it is now. The sheer size and pace of the ...
Read Full Story »